Atlas Trials

Study of PolyIC and PD-1 mAb in Subjects With Unresectable Hepatocellular Carcinoma

Clinical trial NCT03732547 · UNKNOWN

Trial details

NCT number
NCT03732547
Sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Carcinoma, Hepatocellular
Start date
2018-10-22
Primary completion
2021-10-22
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.